[go: up one dir, main page]

ES8708228A1 - Un procedimiento para la obtencion de 8-(4-(4-(1-oxo-1,2-benzoisotiazol-3-il)-1-piperazinil)-butil)-8-azapiro (4,5)decano-7,9-diona. - Google Patents

Un procedimiento para la obtencion de 8-(4-(4-(1-oxo-1,2-benzoisotiazol-3-il)-1-piperazinil)-butil)-8-azapiro (4,5)decano-7,9-diona.

Info

Publication number
ES8708228A1
ES8708228A1 ES554284A ES554284A ES8708228A1 ES 8708228 A1 ES8708228 A1 ES 8708228A1 ES 554284 A ES554284 A ES 554284A ES 554284 A ES554284 A ES 554284A ES 8708228 A1 ES8708228 A1 ES 8708228A1
Authority
ES
Spain
Prior art keywords
formula
antipsychotic
benzisothiazole
oxide compound
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES554284A
Other languages
English (en)
Other versions
ES554284A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES8708228A1 publication Critical patent/ES8708228A1/es
Publication of ES554284A0 publication Critical patent/ES554284A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO DE SINTESIS DE 8-4-4(1-OXO-1,2-BENZOISOTIAZOL-3-IL)-1-PIPERAZINIL-BUTIL-8-AZASPIRO-4,5 -DECANO-7,9-DIONA. CONSISTENTE EN: HACER REACCIONAR A BAJA TEMPERATURA, UN COMPUESTO DE FORMULA (II) CON UNA MEZCLA DE ACIDOS NITRICO Y SULFURICO, PARA OBTENER UN COMPUESTO DE FORMULA (I) EN FORMA BASICA; Y TRANSFORMAR EL PRODUCTO OBTENIDO EN LA ETAPA ANTERIOR EN UNA SAL, FARMACEUTICAMENTE ACEPTABLE, POR REACCION COMUN ACIDO ORGANICO O INORGANICO SELECCIONADO. SE UTILIZA COMO FARMACO ANTIPSICOTICO. *FORMULA*
ES554284A 1985-04-24 1986-04-23 Un procedimiento para la obtencion de 8-(4-(4-(1-oxo-1,2-benzoisotiazol-3-il)-1-piperazinil)-butil)-8-azapiro (4,5)decano-7,9-diona. Expired ES8708228A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/726,449 US4656173A (en) 1985-04-24 1985-04-24 Antipsychotic benzisothiazole S-oxide compound

Publications (2)

Publication Number Publication Date
ES8708228A1 true ES8708228A1 (es) 1987-10-01
ES554284A0 ES554284A0 (es) 1987-10-01

Family

ID=24918649

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554284A Expired ES8708228A1 (es) 1985-04-24 1986-04-23 Un procedimiento para la obtencion de 8-(4-(4-(1-oxo-1,2-benzoisotiazol-3-il)-1-piperazinil)-butil)-8-azapiro (4,5)decano-7,9-diona.

Country Status (26)

Country Link
US (1) US4656173A (es)
JP (1) JPH0764842B2 (es)
KR (1) KR900000372B1 (es)
CN (1) CN1017528B (es)
AT (1) AT394719B (es)
AU (1) AU592787B2 (es)
BE (1) BE904662A (es)
CA (1) CA1247102A (es)
CH (1) CH666034A5 (es)
DE (1) DE3613739C2 (es)
DK (1) DK187686A (es)
EG (1) EG18002A (es)
ES (1) ES8708228A1 (es)
FI (1) FI84604C (es)
FR (1) FR2581064B1 (es)
GB (1) GB2174393B (es)
GR (1) GR861063B (es)
HU (1) HU195654B (es)
IE (1) IE59182B1 (es)
IT (1) IT1208600B (es)
LU (1) LU86405A1 (es)
MY (1) MY102041A (es)
NL (1) NL8601043A (es)
PT (1) PT82450B (es)
SE (1) SE462163B (es)
ZA (1) ZA861531B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
EP0350145A3 (en) * 1988-04-28 1990-07-04 Yamanouchi Pharmaceutical Co. Ltd. Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both
US5077295A (en) * 1988-09-16 1991-12-31 Pfizer Inc. Antipsychoic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)buytl bridged bicycle imides
US4956368A (en) * 1989-07-24 1990-09-11 Bristol-Myers Company Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione
US4968792A (en) * 1989-09-25 1990-11-06 American Home Products Corporation Psychotropic benzisothiazole derivatives
US5162321A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie 1-naphthyl piperazines useful as 5-HT1A receptor ligands
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
CH582699A5 (es) * 1973-03-26 1976-12-15 Sandoz Ag
AT342057B (de) * 1974-04-25 1978-03-10 Thomae Gmbh Dr K Verfahren zur herstellung von neuen 3-piperazino-isochinolinen und deren salzen
FI753625A7 (es) * 1975-01-06 1976-07-07 Spofa Vereinigte Pharma Werke
JPS51144735A (en) * 1975-06-06 1976-12-13 Nippon Nohyaku Co Ltd A remedy for hepatic failure
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives

Also Published As

Publication number Publication date
GR861063B (en) 1986-09-01
SE8601883L (sv) 1986-10-25
BE904662A (fr) 1986-10-23
DK187686A (da) 1986-10-25
FI84604B (fi) 1991-09-13
NL8601043A (nl) 1986-11-17
IE861083L (en) 1986-10-24
KR900000372B1 (ko) 1990-01-25
IE59182B1 (en) 1994-01-26
PT82450A (en) 1986-05-01
DE3613739C2 (de) 1993-12-09
AT394719B (de) 1992-06-10
GB8609932D0 (en) 1986-05-29
SE462163B (sv) 1990-05-14
JPH0764842B2 (ja) 1995-07-12
KR860008174A (ko) 1986-11-12
ZA861531B (en) 1986-10-29
CN1017528B (zh) 1992-07-22
PT82450B (pt) 1988-11-30
AU5612186A (en) 1986-10-30
ATA110486A (de) 1991-11-15
IT8620187A0 (it) 1986-04-23
AU592787B2 (en) 1990-01-25
FI861668A0 (fi) 1986-04-21
HU195654B (en) 1988-06-28
HUT42088A (en) 1987-06-29
DK187686D0 (da) 1986-04-23
US4656173A (en) 1987-04-07
EG18002A (en) 1991-08-30
CA1247102A (en) 1988-12-20
FR2581064A1 (fr) 1986-10-31
FR2581064B1 (fr) 1988-09-16
CN86102742A (zh) 1987-02-04
LU86405A1 (fr) 1986-11-05
ES554284A0 (es) 1987-10-01
CH666034A5 (de) 1988-06-30
MY102041A (en) 1992-02-29
FI861668L (fi) 1986-10-25
GB2174393B (en) 1989-02-01
JPS61251683A (ja) 1986-11-08
SE8601883D0 (sv) 1986-04-23
FI84604C (fi) 1991-12-27
DE3613739A1 (de) 1986-11-20
GB2174393A (en) 1986-11-05
IT1208600B (it) 1989-07-10

Similar Documents

Publication Publication Date Title
ES8704949A1 (es) Procedimiento para preparar nuevas amidas de acidos tieno-triazolo-1,4-diazepino-2-carboxilicos
ES8607221A1 (es) Un procedimiento de producir un compuesto de guanidina acti-vo como fungicida, de baja toxicidad.
SE8605063D0 (sv) Derivatives of cyclohexane
ES8800143A1 (es) Procedimiento para preparar acidos benzoicos trisubsituidos.
ES8708228A1 (es) Un procedimiento para la obtencion de 8-(4-(4-(1-oxo-1,2-benzoisotiazol-3-il)-1-piperazinil)-butil)-8-azapiro (4,5)decano-7,9-diona.
ES8203376A1 (es) Procedimiento para obtener acidos 6-cloro- o 6-bromo-1,2-di-hidro-3h-pirrolo(1,2-a)pirrol-1-carboxilicos y sus derivados
ES492553A0 (es) Un procedimiento para la preparacion de z-2-acilaminoprope- noatos 3-monosustituidos
AR240815A2 (es) Procedimiento para preparar derivados de los acidos benzofuran-5-il y benzotiofen-5-il acetico y propionico
ES8703456A1 (es) Procedimiento para preparar derivados de nitrofurano
IT1190987B (it) Tioesteri dell'acido acetilsalicilico,procedimento per la loro preparazione e composizioni farmaceutiche che li conttengono
ES8600751A1 (es) Procedimiento de producir derivados de acido oxazolacetico.
EP0207436A3 (en) New cytidine-diphosphocholine salts, particularly suitable for oral use
IT8621112A1 (it) Derivati dell'acido tiazolidin-4-carbossilico ad attività farmaceutica
GB1110099A (en) Urea and thiourea derivatives
ES8704871A1 (es) Procedimiento para la fabricacion de acidos 6-alcoxi (inferior)-5-halo-1-naftoicos y sus esteres correspondientes
ES2056072T3 (es) Procedimientos de preparacion del acido (+/-)-1,2-dihidro-3h-pirrolo (1,2-a) pirrol-1-carboxilico y compuestos relacionados.
DE3884508D1 (de) Cystein-derivate mit expectorans-wirkung.
ES8505178A1 (es) Procedimiento para la obtencion de derivados quinolinicos
ES2068209T3 (es) Proceso para la fabricacion de derivados de acidos alifatilfosfinicos.
JPS54144320A (en) Preparation of ureidomethylene malonic ester
ES8308568A1 (es) Un procedimiento para la preparacion de nuevos derivados del 1,1-dioxido del acido penicilanico.
JPS54138556A (en) Preparation of hydantoin
ES8106529A1 (es) Procedimiento para la preparacion de nuevas penicilinas
ES517500A0 (es) Procedimiento para la obtencion del complejo 3-metoxi-n-metilmorfinona y acido teofilinacetico (1:2).
DE3571394D1 (en) A (-) campholenic acid ester of salicylic acid having mucosecretolytic, anti-inflammatory, analgesic antipyretic activity, suitable to provide pharmaceutically acceptable salts; a process for its preparation and pharmaceutical compositions containing the ester or the salts thereof